A review of the implementation of the embryonic stem cell test (EST)

Alternatives to Laboratory Animals

Volumn 37, Issue 3, 2009, Pages 313-328

  Marx Stoelting, Philip ^a   Adriaens, Els ^b   Ahr, Hans Jürgen ^c   Bremer, Susanne ^d   Garthoff, Bernward ^e   Gelbke, Heinz Peter ^f   Piersma, Aldert ^g   Pellizzer, Cristian ^d   Reuter, Ulrike ^h   Rogiers, Vera ⁱ   Schenk, Barbara ^a   Schwengberg, Silke ^j   Seiler, Andrea ^k   Spielmann, Horst ^k   Steemans, Margino ^l   Stedman, Donald B ^m   Vanparys, Philippe ⁿ   Vericat, Joan Albert ^o   Verwei, Miriam ^p   Van De Water, Femke ^q   Weimer, Marc ^r   Schwarz, Michael ^a   more..

^a UNIVERSITY OF TÜBINGEN   (Germany)

^b Adriaens Consulting BVBA   (Belgium)

^c BAYER PHARMA AG   (Germany)

^d JOINT RESEARCH CENTRE   (Italy)

^e BAYER CROPSCIENCE AG   (Germany)

^f BASF SE   (Germany)

^g NATIONAL INSTITUTE FOR PUBLIC HEALTH AND THE ENVIRONMENT   (Netherlands)

^h Evatox Consulting   (Germany)

ⁱ VRIJE UNIVERSITEIT BRUSSEL   (Belgium)

^j Pluriomics BV   (Germany)

^k FEDERAL INSTITUTE FOR RISK ASSESSMENT   (Germany)

^l JANSSEN RESEARCH AND DEVELOPMENT   (Belgium)

^m PFIZER GLOBAL RESEARCH AND DEVELOPMENT   (United States)

ⁿ ALTOXICON BVBA   (Belgium)

^o Drug Discovery   (Spain)

^p TNO   (Netherlands)

^q MERCK RESEARCH LABORATORIES   (United States)

^r GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ASSAY; BIOTECHNOLOGY; CONFERENCE PAPER; CYTOTOXICITY; DECISION MAKING; DRUG INDUSTRY; EMBRYONIC STEM CELL; EMBRYOTOXICITY; GENE; HEART MUSCLE CELL; IN VITRO STUDY; MEASUREMENT; PREDICTION; PRIORITY JOURNAL; SCREENING TEST;

EID: 69849088915     PISSN: 02611929     EISSN: None     Source Type: Journal    
DOI: 10.1177/026119290903700314     Document Type: Conference Paper

References (23)

1. Anon. (2006). RIP: Technical Guidance Documents (TGD). Available at: http://ecb.jrc.it/reach/rip (Accessed 14.05.09).
2. van der Jagt, K., Munn, S., Toersloev, J. & de Bruijn, J. (2004). Alternative Approaches Can Reduce the Use of Test Animals under REACH, 31pp. Ispra, VA, Italy: European Commission Joint Research Centre, Institute for Health and Consumer Protection. Available at: ecb.jrc.ec. europa.eu/ documents/REACH/PUBLICATIONS/Reducing-the-use-of-test-animals-under-REACH-IHCP- report.pdf (Accessed 14.05.09).
3. Cooper, R.L., Lamb, J.C., Barlow, S.M., Bentley, K., Brady, A.M., Doerrer, N.G., Eisenbrandt, D.L., Fenner-Crisp, P.A., Hines, R.N., Irvine, L.F., Kimmel, C.A., Koeter, H., Li, A.A., Makris, S.L., Sheets, L.P., Speijers, G. & Whitby, K.E. (2006). A tiered approach to life stages testing for agricultural chemical safety assessment. Critical Reviews in Toxicology 36, 69-98. (Pubitemid 43372197)
4. Hareng, L., Pellizzer, C., Bremer, S., Schwarz, M. & Hartung, T. (2005). The integrated project ReProTect: a novel approach in reproductive toxicity hazard assessment. Reproductive Toxicology 20, 441-452. (Pubitemid 40943563)
5. Genschow, E., Spielmann, H., Scholz, G., Pohl, I., Seiler, A., Clemann, N., Bremer, S. & Becker, K. (2004). Validation of the embryonic stem cell test in the international ECVAM validation study on three in vitro embryotoxicity tests. ATLA 32, 209-244. (Pubitemid 39517737)
6. Spielmann, H., Pohl, L, Döring, B., Liebsch, M. & Moldenhauer, F. (1997). The embryonic stem cell test (EST), an in vitro embryotoxicity test using two permanent mouse cell lines: 3T3 fibroblasts and embryonic stem cells. Toxicology in Vitro 10, 119-127. (Pubitemid 27234596)
7. Scholz, G., Pohl, I., Genschow, E., Klemm, M. & Spielmann, H. (1999). Embryotoxicity screening using embryonic stem cells in vitro: correlation to in vivo teratogenicity. Cells Tissues Organs 165, 203-211.
8. Seiler, A.E., Buesen, R., Visan, A. & Spielmann, H. (2006). Use of murine embryonic stem cells in embryotoxicity assays: the embryonic stem cell test. Methods in Molecular Biology 329, 371-395.
9. Balls, M. & Hellsten, E. (2002). Statement of the scientific validity of the embryonic stem cell test (EST) - an in vitro test for embryotoxicity. Statement of the scientific validity of the micromass test - an in vitro test for embryotoxicity. Statement of the scientific validity of the postimplantation rat whole embryo culture assay - an in vitro test for embryotoxicity. In ECVAM News and Views. ATLA 30, 265-273.
10. Paquette, J.A., Kumpf, S.W., Streck, R.D., Thomson, J.J., Chapin, R.E. & Stedman, D.B. (2008). Assessment of the Embryonic Stem Cell Test and application and use in the pharmaceutical industry. Birth Defects Research Part B: Developmental & Reproductive Toxicology 83, 104-111.
11. Chapin, R., Stedman, D., Paquette, J., Streck, R., Kumpf, S. & Deng, S. (2007). Struggles for equivalence: in vitro developmental toxicity model evolution in pharmaceuticals in 2006. Toxicology in Vitro 21, 1545-1551. (Pubitemid 350086850)
12. Spielmann, H., Seiler, A., Bremer, S., Hareng, L., Hartung, T., Ahr, H., Faustman, E., Haas, U., Moffat, G.J., Nau, H., Vanparys, P., Piersma, A., Sintes, J.R. & Stuart, J. (2006). The practical application of three validated in vitro embryotoxicity tests. The report and recommendations of an ECVAM/ZEBET workshop (ECVAM Workshop 57). ATLA 34, 527-538. (Pubitemid 44831681)
13. Brown, N.A. (2002). Selection of test chemicals for the ECVAM international validation study on in vitro embryotoxicity tests. ATLA 30, 177-198.
14. zur Nieden, N.I., Kempka, G. & Ahr, H.J. (2004). Molecular multiple endpoint embryonic stem cell test - a possible approach to test for the teratogenic potential of compounds. Toxicology & Applied Pharmacology 194, 257-269.
15. zur Nieden, N.I., Ruf, L.J., Kempka, G., Hildebrand, H. & Ahr, H.J. (2001). Molecular markers in embryonic stem cells. Toxicology in Vitro 15, 455-461.
16. Klemm, M. & Schrattenholz, A. (2004). Neurotoxicity of active compounds - establishment of hESC-lines and proteomics technologies for human embryo- and neurotoxicity screening and biomarker identification. ALTEX 21, Suppl. 3, 41-48. (Pubitemid 38979456)
17. Seiler, A., Visan, A., Buesen, R., Genschow, E. & Spielmann, H. (2004). Improvement of an in vitro stem cell assay for developmental toxicity: the use of molecular endpoints in the embryonic stem cell test. Reproductive Toxicology 18, 231-240. (Pubitemid 38333047)
18. Buesen, R., Genschow, E., Slawik, B., Visan, A., Spielmann, H., Luch, A. & Seiler, A. (2009). Embryonic stem cell test (EST) remastered: comparison between the validated EST and the new molecular FACS-EST for assessing developmental toxicity in vitro. Toxicological Sciences 108, 389-400.
19. Kaltenhaeuser, J., Genschow, E. & Becker, F. (2004). Quantitative gene expression analysis in mouse embryonic stem cells as an indicator of embryotoxic potential. Reproductive Toxicology 18, 707-757.
20. Buesen, R., Visan, A., Genschow, E., Slawik, B., Spielmann, H. & Seiler, A. (2004). Trends in improving the embryonic stem cell test (EST): an overview. ALTEX 21, 15-22. (Pubitemid 38979464)
21. Seiler, A., Buesen, R., Hayess, K., Schlechter, K., Visan, A., Genschow, E., Slawik, B. & Spielmann, H. (2006). Current status of the embryonic stem cell test: the use of recent advances in the field of stem cell technology and gene expression analysis. ALTEX 23, 393-399.
22. Peters, A.K., Steemans, M., Hansen, E., Mesens, N., Verheyen, G.R. & Vanparys, P. (2008). Evaluation of the embryotoxic potency of compounds in a newly revised high throughput embryonic stem cell test. Toxicological Sciences 105, 342-350.
23. Peters, A.K., Wouwer, G.V., Weyn, B., Verheyen, G.R., Vanparys, P. & Gompel, J.V. (2008). Automated analysis of contractility in the embryonic stem cell test, a novel approach to assess embryotoxicity. Toxicology in Vitro 22, 1948-1956.